Updated:
Kyung Dong Pharmaceutical
Kyung Dong Pharmaceutical was established in 1976 by Ryu Deok-hee in Gwacheon, Gyeonggi Province. The company produces pharmaceuticals and maintains...
Kyung Dong Pharmaceutical
Kyung Dong Pharmaceutical was established in 1976 by Ryu Deok-hee in Gwacheon, Gyeonggi Province. The company produces pharmaceuticals and maintains manufacturing plants in Hwaseong. Its investment activity stems from the core pharmaceutical business. The firm pursues a balanced strategy that includes early-stage seed and start-up investments alongside expansion and late-stage commitments. It also holds commercial real estate such as the Smart-K Building and the Inheon-dong office property. Geographic focus remains South Korea with one noted partnership for China expansion through Dasan Pharmaceutical. Ryu Gi-seong serves as Vice Chairman and CEO. The firm employs no disclosed headcount beyond the two named principals. It maintains membership in the Korea Pharmaceutical Manufacturers Association, the Korea Drug Research Association, and the Korea Pharmaceutical Traders Association. No operational events from the last 24 months appear in available records. The corporate structure ties investment decisions directly to the founding family and the underlying pharmaceutical operations, creating a mandate shaped by manufacturing cash flows rather than external LP commitments.
General information
Firm type
Corporate Investor
Year founded
1976
AUM
220 (Altss estimate)
Location
Region
Asia
Country
South Korea
City
Gwacheon
Corporate office
26, Gwacheon-daero 7-gil, Gwacheon-si, Gyeonggi-do, South Korea
Principals
Ryu Deok-hee
Founder and Chairman
Ryu Gi-seong
Vice Chairman and CEO
Sector focus
Frequently asked questions
Who runs investment decisions at Kyung Dong Pharmaceutical?
Ryu Gi-seong serves as Vice Chairman and CEO. His father, founder Ryu Deok-hee, remains Chairman. Decisions align with the company's pharmaceutical manufacturing and real-estate operations.
What asset classes does Kyung Dong Pharmaceutical deploy into?
The firm manufactures pharmaceuticals and holds commercial real estate. It also allocates to early-stage venture investments and health functional food distribution.
Does Kyung Dong Pharmaceutical commit to external funds or make direct investments?
Available records show direct investments and co-promotion agreements such as the partnership with Servier Korea. No external fund commitments are disclosed.
Where does Kyung Dong Pharmaceutical source deal flow?
Sourcing occurs through industry associations including the Korea Pharmaceutical Manufacturers Association and through existing business relationships such as Dasan Pharmaceutical.
What is the relationship between Kyung Dong Pharmaceutical and the Songcheon Scholarship Foundation?
The foundation appears as an adjacent philanthropic vehicle. No further separation or governance details are disclosed in public records.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: